abnormal increase

Scientists have discovered what appears to be the primary driver of tumor development in the stomach. Inhibiting the signaling cascade initiated by the IL-11 protein prevented the development of inflammation, hyperplasia (an abnormal increase in the number of cells) and tumor formation in pre-clinical models of gastric cancer.